These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37761006)

  • 21. Altered responsiveness to glutamatergic modulation by MK-801 and to repeated stress of immune challenge in female dopamine transporter knockout rats.
    Hlavacova N; Hrivikova K; Karailievova L; Karailiev P; Homberg JR; Jezova D
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Aug; 126():110804. PubMed ID: 37247803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits.
    Reinwald JR; Gass N; Mallien AS; Sartorius A; Becker R; Sack M; Falfan-Melgoza C; Clemm von Hohenberg C; Leo D; Pfeiffer N; Middelman A; Meyer-Lindenberg A; Homberg JR; Weber-Fahr W; Gass P
    Mol Psychiatry; 2022 Apr; 27(4):2329-2339. PubMed ID: 35246636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring.
    Kim P; Choi CS; Park JH; Joo SH; Kim SY; Ko HM; Kim KC; Jeon SJ; Park SH; Han SH; Ryu JH; Cheong JH; Han JY; Ko KN; Shin CY
    J Neurosci Res; 2014 May; 92(5):658-70. PubMed ID: 24510599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociations between cognitive and motor effects of psychostimulants and atomoxetine in hyperactive DAT-KO mice.
    Del'Guidice T; Lemasson M; Etiévant A; Manta S; Magno LA; Escoffier G; Roman FS; Beaulieu JM
    Psychopharmacology (Berl); 2014 Jan; 231(1):109-22. PubMed ID: 23912772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine Dysregulation and Altered Responses to Drugs Affecting Dopaminergic Transmission in a New Dopamine Transporter Knockout (DAT-KO) Rat Model.
    Lloyd JT; Yee AG; Kalligappa PK; Jabed A; Cheung PY; Todd KL; Karunasinghe RN; Vlajkovic SM; Freestone PS; Lipski J
    Neuroscience; 2022 May; 491():43-64. PubMed ID: 35331847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions.
    Perona MT; Waters S; Hall FS; Sora I; Lesch KP; Murphy DL; Caron M; Uhl GR
    Behav Pharmacol; 2008 Sep; 19(5-6):566-74. PubMed ID: 18690111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
    Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG
    J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new paradigm for Prosocial Behavior and Reciprocity, assessed in WT and HET rats for the DAT gene.
    Festucci F; Buccheri C; Cerniglia L; Paciello M; Cimino S; Curcio G; Adriani W
    Behav Brain Res; 2020 Sep; 393():112746. PubMed ID: 32502514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altering the development of the dopaminergic system through social play in rats: Implications for anxiety, depression, hyperactivity, and compulsivity.
    Parvopassu A; Oggiano M; Festucci F; Curcio G; Alleva E; Adriani W
    Neurosci Lett; 2021 Aug; 760():136090. PubMed ID: 34197903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Paradigm for Training Hyperactive Dopamine Transporter Knockout Rats: Influence of Novel Stimuli on Object Recognition.
    Kurzina NP; Volnova AB; Aristova IY; Gainetdinov RR
    Front Behav Neurosci; 2021; 15():654469. PubMed ID: 33967714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze.
    Kurzina NP; Aristova IY; Volnova AB; Gainetdinov RR
    Behav Brain Res; 2020 Jul; 390():112642. PubMed ID: 32428629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiscale imaging characterization of dopamine transporter knockout mice reveals regional alterations in spine density of medium spiny neurons.
    Berlanga ML; Price DL; Phung BS; Giuly R; Terada M; Yamada N; Cyr M; Caron MG; Laakso A; Martone ME; Ellisman MH
    Brain Res; 2011 May; 1390():41-9. PubMed ID: 21439946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noradrenergic Modulation of Learned and Innate Behaviors in Dopamine Transporter Knockout Rats by Guanfacine.
    Volnova A; Kurzina N; Belskaya A; Gromova A; Pelevin A; Ptukha M; Fesenko Z; Ignashchenkova A; Gainetdinov RR
    Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine transporter (DAT) genetic hypofunction in mice produces alterations consistent with ADHD but not schizophrenia or bipolar disorder.
    Mereu M; Contarini G; Buonaguro EF; Latte G; Managò F; Iasevoli F; de Bartolomeis A; Papaleo F
    Neuropharmacology; 2017 Jul; 121():179-194. PubMed ID: 28454982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.
    Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME
    J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
    Miller GW; Wang YM; Gainetdinov RR; Caron MG
    Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine Transporter Knockout Rats Display Epigenetic Alterations in Response to Cocaine Exposure.
    Vilca S; Wahlestedt C; Izenwasser S; Gainetdinov RR; Pardo M
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509143
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.